Strategic partnerships
From independent evaluations to collaborations with private providers, governments, donors, and academic institutions, Malaria Consortium’s partnerships amplify our impact — enabling us to deliver high-quality, evidence-based interventions and adapt to emerging health challenges.
Health outcomes depend on factors beyond healthcare alone, including education, environment, infrastructure, and technological innovation. By working with a diverse network of partners that can bring additional value and expertise, we can amplify insight, optimise resources and drive innovation that strengthen health systems for sustainable progress against malaria and other health threats.
Our GiveWell Top Charity status
Malaria Consortium has been recognised as a GiveWell Top Charity since 2016 for our seasonal malaria chemoprevention (SMC) programme, based on its exceptional cost-effectiveness, strong evidence base and robust monitoring systems. GiveWell’s endorsement has enabled Malaria Consortium to expand our reach significantly. We help to protect millions of children annually from malaria, with our programme typically delivering SMC to almost half of all children reached globally with this intervention.
See how strong data collection and digital innovation are improving our delivery of this highly effective health solution.
-
Private sector engagement
The private sector is crucial for delivering high-quality, accessible healthcare, especially where local pharmacists and drug vendors are often the first point of care. In countries like Nigeria, more than half of health services are provided through private channels. We work with stakeholders across supply and delivery chains to improve the availability and affordability of essential malaria products, including quality-assured malaria rapid diagnostic tests (mRDTs) and artemisinin combination therapies (ACTs). By working with private providers, we help create demand for accurate diagnosis and effective treatment, while offering training on case management and RDT procedures, waste management and supervision to ensure high standards of care.
In practice: We supported Nigeria’s National Malaria Elimination Programme to investigate the availability of mRDTs and artemisinin-based combination therapies (ACTs) in Nigeria under special private sector subsidy schemes to address financial barriers to the accessibility of malaria treatment.
Find out about the role of ACTs in treating malaria and the challenges around resistance.
-
Public-Private-Philanthropic partnerships
Public-private-philanthropic partnerships are vital to our mission. By uniting governments, businesses and donors, we amplify resources, innovation and reach to deliver greater health impact where it is needed most. These collaborations help us scale proven interventions and save more lives from malaria and other preventable diseases.
In practice: In Nigeria, we have leveraged public-private-philanthropic partnerships to introduce government-led subsidy schemes for antimalarial medicines to subsidise the cost of quality-assured artemisinin-based combination therapy (ACTs) — the recommended drug for uncomplicated malaria. Working with the Ministry of Health and private sector stakeholders, we are advocating for similar subsidies for malaria rapid diagnostic tests, to ensure that ACTs are used appropriately.
-
Philanthropic partners
Malaria Consortium partners with philanthropic organisations worldwide to expand lifesaving interventions. These collaborations channel evidence-based giving into high-impact programmes, protecting millions from malaria and other diseases. We value our diverse community of philanthropists, from the Effective Altruism community to foundations and individual donors who share our dedication to achieving a world free of malaria where equitable access to healthcare empowers people and enables communities to thrive.
Explore the Effective Altruism organisations that trust us to deliver cost-effective, evidence-based programmes. -
Research partners
We know that our research expertise can be most effective when we work alongside academic partners, informed by the priorities of national programmes. We use our research status to build partnerships with national academic institutions, research bodies, ministries of health and other implementing agencies — enabling us to design and deliver context-specific health interventions and increase the resilience of health systems.
In practice: We have partnered with the London School of Economics to conduct a rigorous economic evaluation of digitalising seasonal malaria chemoprevention (SMC) campaigns in Mozambique. The partnership aims to generate robust evidence to inform policy decisions on the scalability and sustainability of digital tools for malaria prevention in Mozambique and similar settings.
In Uganda, we have partnered with local partner Molecular Research Laboratories and Stanford University to unravel the complex interplay between SMC and children’s immune systems.
Learn how research and continuous learning strengthen health systems.